Holliston, MA – Digilab, Inc. announces the introduction of the ProPrep-LC Automated Protein Digestion Workstation. The ProPrep-LC is designed to perform reliable automation of in-gel and in-solution protein digestion followed by sample preparation for LC-MS. The ProPrep-LC is the only instrument that has been specifically designed for this purpose and provides piece of mind and your samples the best treatment.

The ProPrep-LC comes standard with one reaction block, however can be upgraded to have up to four reaction blocks that can be independently controlled. The ProPrep-LC can also be upgraded to a ProPrep II which allows samples to be spotted to commercially available MALDI plates in addition to LC vials.

The ProPrep-LC performs the digestion in temperature controlled, 96 well, flow-through reaction blocks. The ProPrep-LC offers reagent chilling, the use of multiple enzymes, extremely accurate liquid handling and both In-gel and In-solution digestion. The ProPrep-LC has the ability to perform customizable as well as multiple protocols, and all reactions and liquid handling is performed in a fully enclosed, HEPA filtered environment.

About Digilab, Inc.

Digilab; a global leader in molecular spectroscopy systems for over 40 years focusing on sample preparation, bioinformatics, and detection/analysis tools enabling solutions for the life sciences research and in-vitro diagnostics markets, including pharmaceutical and biotech industries, as well universities and governments.

In September of 2004, Digilab sold its product assets to Varian Inc., Digilab, Inc invested the proceeds of this transaction in a business model focused principally on life science research tools and downstream point of need clinical, safety and security applications.

In June of 2006, Digilab acquired SpectraCode Inc. in West Lafayette, Indiana. This acquisition provides Digilab core competence and products in high growth applications which require the versatility and ease of use of Raman Molecular Spectroscopy.

In November of 2007, Digilab acquired Genomic Solutions (which included Gene Machines, Cartesian, and BioRobotics) and MAIA Scientific. These acquisitions broaden Digilab’s global footprint in both the Life Sciences Research pre-analytics market and its commitment to provide downstream systems and solutions which will have broad application in clinical diagnostics.

Digilab, via a series of acquisitions and partnerships, is implementing this business model. Its vision and strategy is retention/expansion of market awareness as a company with unique and high value products for principally the health sciences markets